Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Nauclea latifolia* extract (derived from the African peach or *Sarcocephalus latifolius*) is a botanical extract traditionally used in West African ethnomedicine for the treatment of malaria, fever, pain, diabetes, and hypertension. A standardized aqueous root extract of the plant, developed under the code name NIPRD-AM1 by the National Institute for Pharmaceutical Research and Development (NIPRD) in Nigeria with support from the World Health Organization, has been clinically evaluated for the treatment of uncomplicated malaria. The extract contains bioactive indole alkaloids, such as strictosamide, which exhibit antiplasmodial activity against *Plasmodium falciparum*. Additionally, preclinical studies have investigated its potential anti-inflammatory, analgesic, and antidiabetic properties, as well as its in vitro cytotoxic activity against various cancer cell lines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nauclea latifolia extract.